The promise of cytokine antibody arrays in the drug discovery process

Bibliography

• MOSMANN TR, FONG TA: Specific assays for cytokine production by T cells. J. brununol. Methods (1989) 116(2):151–158.
   Google Scholar
• HSIEH CS, HEIMBERGER AB, GOLD JS, O'GARRA A, MURPHY KM: Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc. Nati Acad. Sci. USA (1992) 89(13):6065–6069.
   PubMed Web of Science ®Google Scholar
• BARALDI-JUNKINS CA, BECK AC, ROTHSTEIN G: Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol. Oncol Gin North Arm (2000) 14(1):45–61, viii.
   Google Scholar
• GERARD C, ROLLINS BJ: Chemokines and disease. Nat. brununol. (2001) 2(2):108–115.
   PubMed Web of Science ®Google Scholar
• ZAGURY D, GALLO RC: Anti-cytokine Ab immune therapy: present status and perspectives. Drug Discov. Today (2004) 9(2):72–81.
   PubMed Web of Science ®Google Scholar
• ICHINOSE M, BARNES PJ: Cytokine-directed therapy in asthma. Curr. Drug Targets In &min. Allergy (2004) 3(3):263–269.
   PubMedGoogle Scholar
• ANDREAKOS ET, FOXWELL BM, BRENNAN FM, MAINI RN, FELDMANN M: Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev (2002) 13(4-5):299–313.
   PubMed Web of Science ®Google Scholar
• ZAGURY D, LE BUANEC H, BIZZINI B, BURNY A, LEWIS G, GALLO RC: Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev (2003) 14(2):123–137.
   PubMedGoogle Scholar
• BARNES PJ: Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev (2003) 14(6):511–522.
   PubMed Web of Science ®Google Scholar
• ANDREAKOS E: Targeting cytokines in autoimmunity: new approaches, new promise. Expert Opin. Biol. Ther. (2003) 3(3)435–447.
   Google Scholar
• BALKWILL FR: Cytokine therapy of cancer. The importance of knowing the context. Eur. Cytokine Netw. (1994) 5(0379–385.
   PubMedGoogle Scholar
• BURKE F, RELF M, NEGUS R, BALKWILL F: A cytokine profile of normal and malignant ovary. Cytokine (1996) 8(7):578–585.
   PubMed Web of Science ®Google Scholar
• FOTI E, FERRANDINA G, MARTUCCI R et al: IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels. Oncology (1999) 57(3):211–215.
   PubMedGoogle Scholar
• PLANTE M, RUBIN SC, WONG GY, FEDERICI MG, FINSTAD CL, GASTL GA: Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer (1994) 73(7):1882–1888.
   PubMed Web of Science ®Google Scholar
• NEGUS RP, BALKWILL FR: Cytokines in tumour growth, migration and metastasis. World J. Uri)]. (1996) 14(3):157–165.
   PubMed Web of Science ®Google Scholar
• FASCIANI A, D'AMBROGIO G, BOCCI G, LUISI S, ARTINI PG, GENAZZANI AR: Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Feral. Steril (2001) 75(6):1218–1221.
   PubMedGoogle Scholar
• HASSAN MI, KASSIM SK, SAEDA L, LABAN M, KHALIFA A: Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue. Anti-Cancer Res. (1999) 19(6C):5657–5662.
   Google Scholar
• DUAN Z, FELLER AJ, PENSON RT, CHABNER BA, SEIDEN MV: Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin. Cancer Res. (1999) 5(11):3445–3453.
   PubMed Web of Science ®Google Scholar
• PENSON RT, KRONISH K, DUAN Z et al: Cytokines IL- lbeta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int. Gynecol Cancer (2000) 10(1):33–41.
   PubMedGoogle Scholar
• BAMBERGER ES, PERRETT CW: Angiogenesis in epithelian ovarian cancer. Mol. Pathol (2002) 55(6):348–359.
   PubMedGoogle Scholar
• SIECZKIEWICZ GJ, HUSSAIN M, KOHN EC: Angiogenesis and metastasis. Cancer Treat. Res. (2002) 107:353–381.
   PubMedGoogle Scholar
• MORGAN E, VARRO R, Sepulveda H et al.: Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. (2004) 110(3):252–266.
   PubMed Web of Science ®Google Scholar
• CARSON RT, VIGNALI DA: Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. I Immunol. Methods (1999) 227(1-2):41–52.
   PubMed Web of Science ®Google Scholar
• KELLAR KL, DOUGLASS JP: Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. Immunol. Methods (2003) 279(1-2):277–285.
   PubMedGoogle Scholar
• CHAN-HUI PY, STEPHENS K, WARNOCK RA, SINGH S: Applications of eTag trade mark assay platform to systems biology approaches in molecular oncology and toxicology studies. Clin. Immunol. (2004) 111(2):162–174.
   PubMedGoogle Scholar
• TIAN H, CAO L, TAN Y et al: Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis. Nucleic Acids Res. (2004) 32(16):e126.
   Google Scholar
• BOCK C, COLEMAN M, COLLINS B et al.: Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics (2004) 4(3):609–618.
   PubMed Web of Science ®Google Scholar
• PETACH H, GOLD L: Dimensionality is the issue: use of photoaptamers in protein microarrays. Curr. Opin. Biotechnol. (2002) 13(4):309–314.
   PubMed Web of Science ®Google Scholar
• LEE M, WALT DR: A fiber-optic microarray biosensor using aptamers as receptors. Anal. Biochem. (2000) 282(1):142–146.
   PubMedGoogle Scholar
• EKINS R, CHU F: Immunoassay and other ligand assays: present status and future trends. I Int. Fed. Cita Chem. (1997) 9(3):100–109.
   PubMedGoogle Scholar
• EKINS R, CHU F: Multianalyte microspot immunoassay. The microanalytical 'compact disk' of the future. Ann. Biol. Clin. (Paris) (1992) 50(5):337–353.
   PubMedGoogle Scholar
• EKINS RP: Ligand assays: from electrophoresis to miniaturized microarrays. Clin. Chem. (1998) 44(9):2015–2030.
   PubMed Web of Science ®Google Scholar
• ••A stimulating and excellent paperfor reviewing the development of immuno-microarray concept.
   Google Scholar
• SAVIRANTA P, OKON R, BRINKER A, WARASHINA M, EPPINGER J, GEIERSTANGER BH: Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin. Chem. (2004) 50(10): 1907–1920.
   PubMedGoogle Scholar
• HUANG RP: Simultaneous detection of multiple proteins with an array-based enzyme-linked immunosorbent assay (ELISA) and enhanced chemiluminescence (ECD. Clin. Chem. Lab. Med. (2001) 39(3):209–214.
   PubMedGoogle Scholar
• HUANG RP: Detection of multiple proteins in an antibody-based protein microarray system. J. Immunol. Methods (2001) 255(1-2):1–13.
   PubMedGoogle Scholar
• HUANG RP, HUANG R, FAN Y, UN Y: Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal. Biochem. (2001) 294(1):55–62.
   PubMed Web of Science ®Google Scholar
• ••First description of detection of multiplecytokines in patients' serum using cytokine antibody arrays.
   Google Scholar
• UN Y, HUANG R, CAO X, WANG SM, SHI Q, HUANG RP: Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clin. Chem. Lab. Med. (2003) 41(2):139–145.
   PubMedGoogle Scholar
• HUANG RP: Cytokine antibody arrays: a promising tool to identify molecular targets for drug discovery. Comb. Chem. High Throughput Screen (2003) 6(8):769–775.
   PubMedGoogle Scholar
• ••Excellent review for cytokine antibodyarray technology and some applications of cytokine antibody arrays.
   Google Scholar
• HUANG RP: Cytokine protein arrays. Methods Mol. Biol. (2004) 278:215–232.
   Google Scholar
• •A detailed protocol for cytokine antibody arrays.
   Google Scholar
• MEND OZA LG, MCQUARY P, MONGAN A, GANGADHARAN R, BRIGNAC S, EGGERS M: High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). Biotechniques (1999) 27(4):778–6, 788.
   Google Scholar
• •First report for antibody arrays in 96-well plate format.
   Google Scholar
• WIESE R, BELOSLUDTSEV Y, POWDRILL T, THOMPSON P, HOGAN M: Simultaneous multianalyte ELISA performed on a microarray platform. Clin. Chem. (2001) 47(8):1451–1457.
   PubMed Web of Science ®Google Scholar
• KNIGHT PR, SREEKUMAR A, SIDDIQUI J et al.: Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock (2004) 21(1):26–30.
   PubMedGoogle Scholar
• LI Y, SCHUTTE RJ, ABU-SHAKRA A, REICHERT WM: Protein array method for assessing in vitro biomaterial-induced cytokine expression. Biomaterials (2005) 26(10):1081–1085.
   PubMed Web of Science ®Google Scholar
• WOODBURY RL, VARNUM SM, ZANGAR RC: Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. I Proteome Res. (2002) 1(3):233–237.
   PubMed Web of Science ®Google Scholar
• SCHWEITZER B, ROBERTS S, GRIMWADE B et al.: Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. (2002) 20(4):359–365.
   PubMed Web of Science ®Google Scholar
• ••Important study demonstratingthat RCA can significantly enhance detection sensitivity in cytokine antibody arrays.
   Google Scholar
• HUANG R, LIN Y, WANG CC et al: Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. (2002) 62(10):2806–2812.
   PubMedGoogle Scholar
• HAAB BB, DUNHAM MJ, BROWN PO: Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Cenome Biol. (2001) 2(2):RESEARCH0004.
   Google Scholar
• LI Y, NATH N, REICHERT WM: parallel comparison of sandwich and direct label assay protocols on cytokine detection protein arrays. Anal. Chem. 75(19) 5274-5281.
   Google Scholar
• SCHWEITZER B, WILTSHIRE S, LAMBERT J et al.: Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Nati Acad. Sci. USA (2000) 97(18): 10113–10119.
   PubMed Web of Science ®Google Scholar
• FIRE A, XU SQ: Rolling replication of short DNA circles. Proc. Nati Acad. Li. USA (1995) 92(10):4641–4645.
   PubMedGoogle Scholar
• ZHANG DY, BRANDWEIN M, HSUIH TC, LI H: Amplification of target-specific, ligation-dependent circular probe. Gene (1998) 211(2):277–285.
   PubMed Web of Science ®Google Scholar
• THOMAS DC, NARDONE GA, RANDALL SK: Amplification of padlock probes for DNA diagnostics by cascade rolling circle amplification or the polymerase chain reaction. Arch. Pathol. Lab. Med. (1999) 123(12):1170–1176.
   PubMedGoogle Scholar
• VARGAS DL, NASCIMBENE C, KRISHNAN C, ZIMMERMAN AW, PARDO CA: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol (2004) 57(467–81.
   Google Scholar
• •A successful story of application of cytokine antibody arrays in identification potential therapeutic target.
   Google Scholar
• LIN Y, HUANG R, CHEN L et al: Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer (2004) 109(0507–515.
   PubMed Web of Science ®Google Scholar
• NICHOLS MT, GIDEY E, MATZAKOS T et al.: Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology (2004) 40(4):836–846.
   PubMedGoogle Scholar
• TURTINEN LW, PRALL DN, BREMER LA, NAUSS RE, HARTSEL SC: Antibody array-generated profiles of cytokine release from THP-1 leukemic monocytes exposed to different amphotericin B formulations. Antimicrob. Agents Chemother. (2004) 48(2):396–403.
   PubMed Web of Science ®Google Scholar
• •An interesting application of cytokine antibody arrays in attempt to classify antimicrobial agnets.
   Google Scholar
• YAMASAKI M, KITAGAWA T, CHUJO H et al: Physiological difference between free and triglyceride-type conjugated linoleic acid on the immune function of C57BL/6N mice. I Agric. Food Chem. (2004) 52(11):3644–3648.
   PubMedGoogle Scholar
• LIN Y, HUANG R, SANTANAM N, LIU Y, PARTHASARATHY S, HUANG R: Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Lett. (2002) 187(1-2):17.
   PubMed Web of Science ®Google Scholar
• MARTOGLIO AM, TOM BD, STARKEY M, CORPS AN, CHARNOCK-JONES DS, SMITH SK: Changes in tumorigen. Mol Med. (2000) 6(9):750–765.
   PubMed Web of Science ®Google Scholar
• ISMAIL RS, BALDWIN RL, FANG J et al.: Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. (2000) 60(23):6744–6749.
   PubMed Web of Science ®Google Scholar
• WELSH JB, ZARRINKAR PP, SAPINOSO LM et al.: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA (2001) 98(3):1176–1181.
   PubMed Web of Science ®Google Scholar
• SAWIRIS GP, SHERMAN-BAUST CA, BECKER KG, CHEADLE C, TEICHBERG D, MORIN PJ: Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res. (2002) 62(10):2923–2928.
   PubMed Web of Science ®Google Scholar
• KAUKOLA T, SATYARAJ E, PATEL DD et al: Cerebral palsy is characterized by protein mediators in cord serum. Ann. Neurol. (2004) 55(2):186–194.
   PubMedGoogle Scholar
• •An exciting report for identification of potential biomarker for cerebral palsy using cytokine antibody arrays coupled with RCA.
   Google Scholar
• CELIS JE, GROMOV P, CABEZON T et al: Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell. Proteomics (2004) 3(4):327–344.
   PubMed Web of Science ®Google Scholar
• POCKAJ BA, BASU GD, PATHANGEY LB et al.: Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann. &mg. Oncol (2004) 11(3):328–339.
   PubMedGoogle Scholar
• HUANG R, LIN Y, FLOWERS L, LISOUKOV H et al.: molecular profiling of cytokine levels in human ovarian cancer patients. 1, 23–32.2004.
   Google Scholar
• TADROS Y, RUIZ-DEYA G, CRAWFORD BE, THOMAS R, ABDEL-MAGEED AB: LI vivo proteomic analysis of cytokine expression in laser capture-microdissected urothelial cells of obstructed ureteropelvic junction procured by laparoscopic dismembered pyeloplasty. Endourol (2003) 17(5):333–336.
   PubMedGoogle Scholar
• •A successful story of application of cytokine antibody arrays in laser-captured microdissection tissues.
   Google Scholar
• KINGSMORE SF, PATEL DD: Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification. Curl: Opin. Biotechnol (2003) 14(1):74–81.
   PubMed Web of Science ®Google Scholar
• HUANG L, ZHAO A, WONG F et al: Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vase. Biol. (2004) 24(10):1783–1788.
   PubMedGoogle Scholar
• •A report from big pharmaceutical company demonstrating the use of cytokine antibody arrays in their drug discovery program.
   Google Scholar
• XU Y, KULKOSKY J, ACHEAMPONG E, NUNNARI G, SULLIVAN J, POMERANTZ RJ: HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc. Natl. Acad. Li. USA (2004) 101(18):7070–7075.
   PubMedGoogle Scholar
• •Cytokine antibody arrays were used to exploit molecular mechanism responsible for the HIV-1-induced encephalopathy.
   Google Scholar
• GIROUX M, DENIS F: Human CD 1d-unrestricted NKT cells release chemokines upon Fas engagement. Blood (2004).
   Google Scholar
• POTIAN JA, AVIV H, PONZIO NM, HARRISON JS, RAMESHWAR P: Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. Immunol (2003) 171(43426–3434.
   Google Scholar
• NELSON BP, GRIMSRUD TE, LILES MR, GOODMAN RM, CORN RM: Surface plasmon resonance imaging measurements of DNA and RNA hybridization adsorption onto DNA microarrays. Anal. Chem. (2001) 73(1):1–7.
   PubMed Web of Science ®Google Scholar
• PAWLAK M, SCHICK E, BOPP MA, SCHNEIDER MJ, OROSZLAN P, EHRAT M: Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics (2002) 2(4):383–393.
   PubMedGoogle Scholar
• PEI R, CHENG Z, WANG E, YANG X: Amplification of antigen-antibody interactions based on biotin labeled protein-streptavidin network complex using impedance spectroscopy. Biosens. Bioelectron. (2001) 16(6):355–361.
   PubMedGoogle Scholar
• WU G, DATAR RH, HANSEN KM, THUNDAT T, COTE RJ, MAJUMDAR A: Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotechnol (2001) 19(9):856–860.
   PubMed Web of Science ®Google Scholar
• HUANG R, LIN Y, SHI Q et al: Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma. Clin. Cancer Res. (2004) 10(2):598–609.
   PubMedGoogle Scholar
• WANG Y, WU TR, CAI S, WELTE T, CHIN YE: Statl as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell. Biol. (2000) 20(13):4505–4512.
   PubMedGoogle Scholar
• SCHARPF R, GARRETT ES, HU J, PARMIGIANI G: Statistical modeling and visualization of molecular profiles in cancer. Biotechnigues (2003) Suppl.:22–29.
   Google Scholar
• OCHS MF, GOD WIN AK: Microarrays n cancer: research and applications. Biotechnigues (2003) Suppl.:4–15.
   Google Scholar
• RINGNER M, PETERSON C: Microarray-based cancer diagnosis with artificial neural networks. Biotechnigues (2003) Suppl.:30–35.
   Google Scholar